Registered entities
Personal Genome Diagnostics Inc.
Reg. No. 5838663United States
Innovation
16 patent families (9 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 979 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 10 |
| 2022 | 8 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 10 |
| 2026 | 3 |
Investor mix
19 investors on record; lead investors include Bristol-Myers Squibb, New Enterprise Associates, Cowen, Innovatus Capital Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 37% |
| Private equity | 6 | 32% |
| Bank & private debt | 2 | 11% |
| Other / undisclosed | 4 | 21% |